SCHEMBL21692598

SCHEMBL21692598

N#Cc1cccc(C#N)c1-c1cc(-c2ccc3sc4ccccc4c3c2)c(C#N)c(-c2cccc3sc4ccccc4c23)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.34
BRDT Q58F21 1/20 0.33
SLC22A12 Q96S37 1/20 0.31
CYP1A2 P05177 4/20 0.31
CYP3A4 P08684 4/20 0.31
ALDH1A1 P00352 3/20 0.31
HSD17B10 Q99714 3/20 0.31
HPGD P15428 3/20 0.31
PIM1 P11309 1/20 0.31
MAPK1 P28482 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
GPR3 P46089 1/20 0.30
KDM4E B2RXH2 2/20 0.30
MEN1 O00255 2/20 0.30
MAPT P10636 2/20 0.30
KMT2A Q03164 2/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
DUSP3 P51452 1/20 0.30
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21691599 0.94 ALOX5 (0.34) ALOX5BRDTSLC22A12ALDH1A1HPGD
SCHEMBL21692597 0.92 ALOX5 (0.35) ALOX5BRDTSLC22A12CYP1A2CYP3A4
SCHEMBL21691706 0.92 CYP1A2 (0.35) ALOX5BRDTSLC22A12CYP1A2CYP3A4
SCHEMBL21692599 0.92 BRDT (0.34) ALOX5BRDTSLC22A12PIM1GPR3
SCHEMBL21692993 0.92 ALOX5 (0.36) ALOX5SLC22A12CYP1A2CYP3A4ALDH1A1
SCHEMBL21693078 0.92 BRDT (0.37) ALOX5BRDTSLC22A12PIM1GPR3
SCHEMBL21691707 0.90 ALOX5 (0.35) ALOX5SLC22A12CYP1A2CYP3A4ALDH1A1
SCHEMBL21692568 0.89 ALOX5 (0.44) ALOX5BRDTSLC22A12CYP1A2CYP3A4
SCHEMBL21691674 0.89 ALOX5 (0.33) ALOX5BRDTSLC22A12CYP1A2CYP3A4
SCHEMBL21691693 0.89 ALDH1A1 (0.35) ALOX5SLC22A12CYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885BRDT 1092/4885SLC22A12 3782/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885BRDT 1092/4885SLC22A12 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.